ClinVar Miner

Submissions for variant NM_001018115.3(FANCD2):c.3707G>A (p.Arg1236His)

gnomAD frequency: 0.00001  dbSNP: rs121917786
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Illumina Laboratory Services, Illumina RCV000012818 SCV001306349 uncertain significance Fanconi anemia complementation group D2 2017-04-27 criteria provided, single submitter clinical testing This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance.
Ambry Genetics RCV001265744 SCV001443913 pathogenic Inborn genetic diseases 2019-02-04 criteria provided, single submitter clinical testing
Invitae RCV002512995 SCV003448545 likely pathogenic Fanconi anemia 2023-09-14 criteria provided, single submitter clinical testing This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 1236 of the FANCD2 protein (p.Arg1236His). This variant is present in population databases (rs121917786, gnomAD 0.003%). This missense change has been observed in individual(s) with Fanconi anemia (PMID: 11239453, 17436244). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 12038). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt FANCD2 protein function. Studies have shown that this missense change is associated with altered splicing resulting in unknown protein product impact (PMID: 17436244). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.
Baylor Genetics RCV000012818 SCV004196725 likely pathogenic Fanconi anemia complementation group D2 2023-09-26 criteria provided, single submitter clinical testing
OMIM RCV000012818 SCV000033058 pathogenic Fanconi anemia complementation group D2 2001-02-01 no assertion criteria provided literature only
Leiden Open Variation Database RCV000012818 SCV001364797 pathogenic Fanconi anemia complementation group D2 2020-02-28 no assertion criteria provided curation Curator: Arleen D. Auerbach. Submitter to LOVD: Arleen D. Auerbach.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.